Published in Nutr J on June 17, 2014
Association of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study. JAMA Pediatr (2016) 1.46
T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases. J Neuroinflammation (2014) 0.91
Genetics of Type 2 Diabetes and Clinical Utility. Genes (Basel) (2015) 0.86
Blood-based signatures in type 1 diabetes. Diabetologia (2015) 0.84
Probiotics and immunity: provisional role for personalized diets and disease prevention. EPMA J (2015) 0.84
Effect of Probiotics on Glycemic Control: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials. PLoS One (2015) 0.82
SLE: Another Autoimmune Disorder Influenced by Microbes and Diet? Front Immunol (2015) 0.81
Mechanisms Linking the Gut Microbiome and Glucose Metabolism. J Clin Endocrinol Metab (2016) 0.80
The Role of Gut Microflora and the Cholinergic Anti-inflammatory Neuroendocrine System in Diabetes Mellitus. Front Endocrinol (Lausanne) (2016) 0.78
Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1. Front Immunol (2016) 0.77
Commensal A4 bacteria inhibit intestinal Th2-cell responses through induction of dendritic cell TGF-β production. Eur J Immunol (2016) 0.77
Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models. Dig Dis Sci (2016) 0.76
Systemic effects of gut microbiota and its relationship with disease and modulation. BMC Immunol (2015) 0.76
Production of a mouse strain with impaired glucose tolerance by systemic heterozygous knockout of the glucokinase gene and its feasibility as a prediabetes model. Exp Anim (2015) 0.75
Is there a value for probiotic supplements in gestational diabetes mellitus? A randomized clinical trial. J Health Popul Nutr (2015) 0.75
Bacterial Flora Changes in Conjunctiva of Rats with Streptozotocin-Induced Type I Diabetes. PLoS One (2015) 0.75
Nutrition Considerations for Microbiota Health in Diabetes. Diabetes Spectr (2016) 0.75
Potential of Lactobacillus plantarum CCFM639 in Protecting against Aluminum Toxicity Mediated by Intestinal Barrier Function and Oxidative Stress. Nutrients (2016) 0.75
Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases. Glycoconj J (2015) 0.75
Early pregnancy probiotic supplementation with Lactobacillus rhamnosus HN001 may reduce the prevalence of gestational diabetes mellitus: a randomised controlled trial. Br J Nutr (2017) 0.75
Effect of symbiotic supplementation on glycemic control, lipid profiles and microalbuminuria in patients with non-obese type 2 diabetes: a randomized, double-blind, clinical trial. J Diabetes Metab Disord (2017) 0.75
Microbial ecology: human gut microbes associated with obesity. Nature (2006) 36.98
Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol (2001) 25.63
Insulin signalling and the regulation of glucose and lipid metabolism. Nature (2001) 16.41
Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes (2007) 14.12
A microbial symbiosis factor prevents intestinal inflammatory disease. Nature (2008) 13.15
Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature (2008) 12.45
Origin and physiological roles of inflammation. Nature (2008) 11.68
Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe (2008) 11.08
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes (2008) 10.74
Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A (2010) 9.81
Incidence of diabetes in youth in the United States. JAMA (2007) 8.70
The NOD mouse: a model of immune dysregulation. Annu Rev Immunol (2005) 6.71
Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One (2010) 6.48
Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature (2010) 5.16
Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr (1999) 5.13
Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity (2011) 4.86
Toll-like receptors and innate immunity. Biochem Biophys Res Commun (2009) 4.26
High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut (2008) 4.10
Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab (2006) 3.84
(S)NO signals: translocation, regulation, and a consensus motif. Neuron (1997) 3.67
Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology (2009) 3.67
Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci U S A (2011) 3.55
Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett (2009) 3.48
Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur J Immunol (2009) 3.42
Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes (2010) 3.39
Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia (2006) 3.21
Toward defining the autoimmune microbiome for type 1 diabetes. ISME J (2010) 3.03
Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol (2010) 2.84
Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care (2009) 2.83
Prebiotics: the concept revisited. J Nutr (2007) 2.83
The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes (2008) 2.77
The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des (2009) 2.65
Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest (1993) 2.64
The immune system and the gut microbiota: friends or foes? Nat Rev Immunol (2010) 2.38
Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes (2009) 2.27
Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci U S A (2010) 2.26
Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol Endocrinol (2003) 2.25
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med (2011) 2.25
Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes (2012) 2.22
Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia (2005) 2.21
Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One (2011) 2.18
Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol (2006) 2.06
Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia (2011) 2.00
Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol (2010) 1.92
Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition (2006) 1.92
Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. Br J Nutr (2008) 1.91
Probiotic bacteria and intestinal epithelial barrier function. Am J Physiol Gastrointest Liver Physiol (2010) 1.90
TLR accessory molecules. Curr Opin Immunol (2008) 1.84
Microbes, immunoregulation, and the gut. Gut (2005) 1.80
The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol (2010) 1.79
Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol (2008) 1.78
Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care (2007) 1.75
Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J (2009) 1.74
Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol (2011) 1.72
Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med (2013) 1.71
Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One (2010) 1.70
Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia (2006) 1.65
Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol (2010) 1.60
Influence of microbial environment on autoimmunity. Nat Immunol (2009) 1.59
Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One (2012) 1.59
Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care (2011) 1.55
Toll-like receptors: linking inflammation to metabolism. Trends Endocrinol Metab (2010) 1.52
Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients. Dig Liver Dis (2004) 1.47
Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition (2011) 1.47
The cadherin-catenin complex as a focal point of cell adhesion and signalling: new insights from three-dimensional structures. Bioessays (2004) 1.46
Beta cell apoptosis in diabetes. Apoptosis (2009) 1.45
Mechanisms of circulatory and intestinal barrier dysfunction during whole body hyperthermia. Am J Physiol Heart Circ Physiol (2001) 1.44
The changing epidemiology of type 1 diabetes: why is it going through the roof? Diabetes Metab Res Rev (2010) 1.41
Lactobacillus fermentum ME-3 - an antimicrobial and antioxidative probiotic. Microb Ecol Health Dis (2009) 1.38
Virus-induced autoimmune diabetes: most beta-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) cytotoxic T-lymphocytes. Diabetes (2000) 1.38
Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infect Immun (2006) 1.35
Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. J Immunol (2011) 1.34
Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes (1999) 1.32
Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. Diabetes (2000) 1.31
Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. Br J Nutr (2010) 1.29
TLR4 and Insulin Resistance. Gastroenterol Res Pract (2010) 1.27
Roles of mTOR and JNK in serine phosphorylation, translocation, and degradation of IRS-1. Biochem Biophys Res Commun (2005) 1.26
The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. Biochem J (2009) 1.25
Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. Cardiovasc Diabetol (2009) 1.22
Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflamm Bowel Dis (2010) 1.22
Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats. J Endocrinol (2005) 1.21
Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes. J Pediatr Gastroenterol Nutr (2005) 1.17
Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr (2010) 1.16
Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab (2002) 1.12
Prevention of virus-induced type 1 diabetes with antibiotic therapy. J Immunol (2012) 1.11
AMP-18 protects barrier function of colonic epithelial cells: role of tight junction proteins. Am J Physiol Gastrointest Liver Physiol (2005) 1.10
Probiotics, immunomodulation, and health benefits. Adv Exp Med Biol (2008) 1.08
Intestinal microflora and metabolic diseases. Diabetes Metab (2009) 1.08
Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats. J Dairy Res (2008) 1.06
Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia (2012) 1.04
VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation. PLoS One (2012) 1.02
Role of Toll-like receptors in infection and immunity: clinical implications. Drugs (2006) 1.01
Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus. Lipids Health Dis (2012) 1.00
Oral administration of butyrivibrio fibrisolvens, a butyrate-producing bacterium, decreases the formation of aberrant crypt foci in the colon and rectum of mice. J Nutr (2005) 0.99
Autoimmune disease in the era of the metagenome. Autoimmun Rev (2009) 0.99
Effect of the orlistat on serum endotoxin lipopolysaccharide and adipocytokines in South Asian individuals with impaired glucose tolerance. Int J Clin Pract (2008) 0.98
The influence of polyunsaturated fatty acids on probiotic growth and adhesion. FEMS Microbiol Lett (2001) 0.98
Liver-specific inducible nitric-oxide synthase expression is sufficient to cause hepatic insulin resistance and mild hyperglycemia in mice. J Biol Chem (2011) 0.97
Exercise training in rats impairs the replenishment of white adipose tissue after partial lipectomy. Eur J Appl Physiol (2010) 0.76